Therapy Gaps for Patients with Heart Failure and Reduced Kidney Function: A Prospective Cohort Study
Gaps in HF therapy use persist in patients with comorbid kidney dysfunction. Targeted strategies to implement new therapies and improve adherence to HF treatments are necessary to improve outcomes in a highly comorbid and at-risk population.
Authors
- Gavin Y. Oudit (ORCID: https://orcid.org/0000-0002-9154-9028)
- Arthur Qi
- Chandu Sadasivan (ORCID: https://orcid.org/0009-0007-4077-4261)
- Finlay A. McAlister (ORCID: https://orcid.org/0000-0001-7435-3341)
- Chen-Hsiang Ma (ORCID: https://orcid.org/0000-0002-0757-7609)
- Luke Gagnon
- Ben Vandermeer (ORCID: https://orcid.org/0000-0001-7449-5251)
- Somkanya Tungsanga (ORCID: https://orcid.org/0000-0002-2640-1131)
- Anukul Ghimire (ORCID: https://orcid.org/0000-0001-9165-4920)
- Matthew Adam Cooper (ORCID: https://orcid.org/0000-0003-3663-1018)
- Bonaventure Oguaju
- Kaiming Wang (ORCID: https://orcid.org/0000-0003-0652-2347)
- Aminu K. Bello (ORCID: https://orcid.org/0000-0001-5021-5542)
Institutions
- University of Alberta (CA)
- Chulalongkorn University (TH)
- University of Calgary (CA)
- University of Toronto (CA)
- Canadian Patient Safety Institute (CA)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2025-11-16
- DOI
- https://doi.org/10.1002/ehf2.70008
- Citations
- 4
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.55
Funders
- Heart and Stroke Foundation of Canada
- Alberta Health Services